{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:18:23Z","timestamp":1792801103876,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Zhejiang Province","award":["LMS25H280001, LMS25H030001, Q24H280064"],"award-info":[{"award-number":["LMS25H280001, LMS25H030001, Q24H280064"]}]},{"name":"the administration of traditional Chinese Medicine of Zhejiang province","award":["GZY-KJS-ZJ-2025-080, 2024ZF056"],"award-info":[{"award-number":["GZY-KJS-ZJ-2025-080, 2024ZF056"]}]},{"name":"Zhejiang Medical and Health Science and Technology Plan Project","award":["2024KY917"],"award-info":[{"award-number":["2024KY917"]}]},{"name":"Basic Scientific Research Funds of Department of Education of Zhejiang Province","award":["KYYB2023002, KYYB2023017"],"award-info":[{"award-number":["KYYB2023002, KYYB2023017"]}],"id":[{"id":"https:\/\/ror.org\/05gj07w56","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82300589, 82360805"],"award-info":[{"award-number":["82300589, 82360805"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Ulcerative colitis (UC), a chronic inflammatory bowel disease, remains an unmet medical need.\n                      <jats:italic>Lindera aggregata,<\/jats:italic>\n                      a traditional Chinese medicine used in treating gastrointestinal disorders, has demonstrated anti-UC efficacy, though its bioactive components are poorly characterized. Isolinderalactone (ILDL), a characteristic sesquiterpene lactone isolated from\n                      <jats:italic>Lindera aggregata<\/jats:italic>\n                      , has been demonstrated anti-cancer properties. However, its therapeutic potential in UC remains unexplored.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Lipopolysaccharide (LPS)-induced RAW264.7 inflammatory cell model was used to screen the anti-inflammatory properties of\n                      <jats:italic>Lindera aggregata<\/jats:italic>\n                      's characteristic compounds in vitro. DSS induced UC mouse model was used to study the anti-UC efficacy of ILDL in vivo. Transcriptomic was used to explore the anti-inflammatory mechanism of ILDL. Drug affinity responsible target stability was used to identify the combination of the ILDL and LXR\u03b1. LXR-mediated effects were further assessed via flow cytometry and Western blotting.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      ILDL effectively inhibits macrophage polarization and the production of inflammatory mediators in vitro, and improves symptoms and tissue lesions in acute UC mice in\n                      <jats:italic>vivo<\/jats:italic>\n                      . Transcriptomic analysis revealed the involvement of the LXR-mediated pathway in ILDL\u2019s effects. Furthermore, ILDL was able to bind to LXR\u03b1 and to upregulate LXR\u03b1 target genes expression such as ABCA1, suggesting that ILDL itself can activate the LXR\u03b1 pathway. Genetic\/pharmacological LXR\u03b1 inhibition abrogated ILDL's anti-inflammatory effects, confirming an LXR\u03b1-dependent mechanism. In addition to inhibiting macrophage M1 polarization, the activation of LXR\u03b1 by ILDL can also promote macrophage efferocytosis of apoptotic intestinal epithelial cells in the co-culture system.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      ILDL activates the LXR\u03b1 pathway, inhibiting macrophage M1 polarization, reducing pro-inflammatory mediators production, and promoting macrophage efferocytosis. ILDL is a promising candidate compound from\n                      <jats:italic>Lindera aggregata<\/jats:italic>\n                      for anti-inflammation and UC treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-025-01216-9","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:03:32Z","timestamp":1759277012000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Isolinderalactone regulates macrophage polarization and efferocytosis by activating the LXR\u03b1 pathway against ulcerative colitis"],"prefix":"10.1186","volume":"20","author":[{"given":"Mincong","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cailu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"issue":"1","key":"1216_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-33138-7","volume":"13","author":"Z Khademi","year":"2023","unstructured":"Khademi Z, Saneei P, Hassanzadeh-Keshteli A, et al. Association between food-based dietary inflammatory potential and ulcerative colitis: a case-control study. Sci Rep. 2023;13(1):8464.","journal-title":"Sci Rep"},{"issue":"1","key":"1216_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00535-022-01927-y","volume":"58","author":"T Noguchi","year":"2023","unstructured":"Noguchi T, Ishihara S, Uchino M, et al. Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn\u2019s disease. J Gastroenterol. 2023;58(1):14\u201324.","journal-title":"J Gastroenterol"},{"issue":"2","key":"1216_CR3","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s12325-022-02364-2","volume":"40","author":"M Regueiro","year":"2023","unstructured":"Regueiro M, Hunter T, Lukanova R, et al. Burden of fatigue among patients with ulcerative colitis and Crohn\u2019s disease: results from a global survey of patients and gastroenterologists. Adv Ther. 2023;40(2):474\u201388.","journal-title":"Adv Ther"},{"issue":"10401","key":"1216_CR4","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","volume":"402","author":"C Le Berre","year":"2023","unstructured":"Le Berre C, Honap S, Peyrin-Biroulet L. Ulcerative colitis. Lancet. 2023;402(10401):571\u201384.","journal-title":"Lancet"},{"issue":"1","key":"1216_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/ibd\/izab039","volume":"28","author":"AS Faye","year":"2022","unstructured":"Faye AS, Colombel JF. Aging and IBD: a new challenge for clinicians and researchers. Inflamm Bowel Dis. 2022;28(1):126\u201332.","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"1216_CR6","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1093\/ibd\/izab355","volume":"28","author":"MAF Berbisa","year":"2022","unstructured":"Berbisa MAF, Nielsen KR, Ingham AC, et al. Similar gut bacterial composition between patients with ulcerative colitis and healthy controls in a high incidence population: a cross-sectional study of the Faroe Islands IBD cohort. Inflamm Bowel Dis. 2022;28(7):1081\u20139.","journal-title":"Inflamm Bowel Dis"},{"key":"1216_CR7","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.2147\/JIR.S440076","volume":"16","author":"R Hua","year":"2023","unstructured":"Hua R, Qiao G, Chen G, et al. Single-Cell RNA-sequencing analysis of colonic lamina propria immune cells reveals the key immune cell-related genes of ulcerative colitis. J Inflamm Res. 2023;16:5171\u201388.","journal-title":"J Inflamm Res"},{"issue":"23","key":"1216_CR8","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1016\/j.cell.2022.10.007","volume":"185","author":"MD Park","year":"2022","unstructured":"Park MD, Silvin A, Ginhoux F, et al. Macrophages in health and disease. Cell. 2022;185(23):4259\u201379.","journal-title":"Cell"},{"issue":"1","key":"1216_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/mi.2015.48","volume":"9","author":"MK Magnusson","year":"2016","unstructured":"Magnusson MK, Brynjolfsson SF, Dige A, et al. Macrophage and dendritic cell subsets in IBD: ALDH+ cells are reduced in colon tissue of patients with ulcerative colitis regardless of inflammation. Mucosal Immunol. 2016;9(1):171\u201382.","journal-title":"Mucosal Immunol"},{"issue":"6","key":"1216_CR10","first-page":"1297","volume":"21","author":"D Lissner","year":"2015","unstructured":"Lissner D, Schumann M, Batra A, et al. Monocyte and M1 macrophage-induced barrier defect contributes to chronic intestinal inflammation in IBD. Inflamm Bowel Dis. 2015;21(6):1297\u2013305.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"1216_CR11","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.cmet.2020.01.001","volume":"31","author":"A Yurdagul Jr","year":"2020","unstructured":"Yurdagul A Jr, Subramanian M, Wang X, et al. Macrophage metabolism of apoptotic cell-derived arginine promotes continual efferocytosis and resolution of injury. Cell Metab. 2020;31(3):518\u201333.","journal-title":"Cell Metab"},{"issue":"4","key":"1216_CR12","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.4049\/jimmunol.1601520","volume":"198","author":"MR Elliott","year":"2017","unstructured":"Elliott MR, Koster KM, Murphy PS. Efferocytosis signaling in the regulation of macrophage inflammatory responses. J Immunol. 2017;198(4):1387\u201394.","journal-title":"J Immunol"},{"issue":"12","key":"1216_CR13","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1016\/j.cmet.2021.10.015","volume":"33","author":"BD Gerlach","year":"2021","unstructured":"Gerlach BD, Ampomah PB, Yurdagul A Jr, et al. Efferocytosis induces macrophage proliferation to help resolve tissue injury. Cell Metab. 2021;33(12):2445\u201363.","journal-title":"Cell Metab"},{"issue":"7","key":"1216_CR14","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1002\/eji.201546262","volume":"46","author":"J Angsana","year":"2016","unstructured":"Angsana J, Chen J, Liu L, et al. Efferocytosis as a regulator of macrophage chemokine receptor expression and polarization. Eur J Immunol. 2016;46(7):1592\u20139.","journal-title":"Eur J Immunol"},{"issue":"2","key":"1216_CR15","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/cbf.3780","volume":"41","author":"S Razi","year":"2023","unstructured":"Razi S, Yaghmoorian Khojini J, Kargarijam F, et al. Macrophage efferocytosis in health and disease. Cell Biochem Funct. 2023;41(2):152\u201365.","journal-title":"Cell Biochem Funct"},{"key":"1216_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.754475","volume":"12","author":"O Martin-Rodriguez","year":"2021","unstructured":"Martin-Rodriguez O, Gauthier T, Bonnefoy F, et al. Pro-resolving factors released by macrophages after efferocytosis promote mucosal wound healing in inflammatory bowel disease. Front Immunol. 2021;12:754475.","journal-title":"Front Immunol"},{"issue":"4","key":"1216_CR17","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.jcmgh.2022.01.002","volume":"13","author":"D Meriwether","year":"2022","unstructured":"Meriwether D, Jones AE, Ashby JW, et al. Macrophage COX2 mediates efferocytosis, resolution reprogramming, and intestinal epithelial repair. Cell Mol Gastroenterol Hepatol. 2022;13(4):1095\u2013120.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1216_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.1071276","author":"Y Lv","year":"2023","unstructured":"Lv Y, Zou Y, Zhang X, et al. A review on the chemical constituents and pharmacological efficacies of Lindera aggregata (Sims) Kosterm. Front Nutr. 2023. https:\/\/doi.org\/10.3389\/fnut.2022.1071276.","journal-title":"Front Nutr"},{"key":"1216_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.615506","volume":"12","author":"H Lai","year":"2021","unstructured":"Lai H, Yang Z, Lou Z, et al. Root extract of Lindera aggregata (Sims) Kosterm. modulates the Th17\/Treg balance to attenuate DSS-induced colitis in mice by IL-6\/STAT3 signaling pathway. Front Pharmacol. 2021;12:615506.","journal-title":"Front Pharmacol"},{"key":"1216_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814246","author":"JS Chen","year":"2023","unstructured":"Chen JS, Chiu SC, Huang SY, et al. Isolinderalactone induces apoptosis, autophagy, cell cycle arrest and MAPK activation through ROS-mediated signaling in colorectal cancer cell lines. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241814246.","journal-title":"Int J Mol Sci"},{"key":"1216_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.canlet.2018.11.027","volume":"443","author":"JY Hwang","year":"2019","unstructured":"Hwang JY, Park JH, Kim MJ, et al. Isolinderalactone regulates the BCL-2\/caspase-3\/PARP pathway and suppresses tumor growth in a human glioblastoma multiforme xenograft mouse model. Cancer Lett. 2019;443:25\u201333.","journal-title":"Cancer Lett"},{"key":"1216_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/0471142735.im1525s104","volume":"104","author":"B Chassaing","year":"2014","unstructured":"Chassaing B, Aitken JD, Malleshappa M, et al. Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol. 2014;104:15 25 1\u201315 25 14.","journal-title":"Curr Protoc Immunol"},{"key":"1216_CR23","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/978-1-4939-2269-7_22","volume":"1263","author":"MY Pai","year":"2015","unstructured":"Pai MY, Lomenick B, Hwang H, et al. Drug affinity responsive target stability (DARTS) for small-molecule target identification. Methods Mol Biol. 2015;1263:287\u201398.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"1216_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jmb.2010.04.005","volume":"399","author":"X Fradera","year":"2010","unstructured":"Fradera X, Vu D, Nimz O, et al. X-ray structures of the LXRalpha LBD in its homodimeric form and implications for heterodimer signaling. J Mol Biol. 2010;399(1):120\u201332.","journal-title":"J Mol Biol"},{"issue":"1","key":"1216_CR25","first-page":"57","volume":"17","author":"MF Sanner","year":"1999","unstructured":"Sanner MF. Python: a programming language for software integration and development. J Mol Graph Model. 1999;17(1):57\u201361.","journal-title":"J Mol Graph Model"},{"issue":"1","key":"1216_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00128336","volume":"4","author":"JJ Stewart","year":"1990","unstructured":"Stewart JJ. MOPAC: a semiempirical molecular orbital program. J Comput Aided Mol Des. 1990;4(1):1\u2013105.","journal-title":"J Comput Aided Mol Des"},{"issue":"8","key":"1216_CR27","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier JA, Martinez C, Kasavajhala K, et al. Ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput. 2015;11(8):3696\u2013713.","journal-title":"J Chem Theory Comput"},{"issue":"8","key":"1216_CR28","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1111\/j.1476-5381.2011.01202.x","volume":"162","author":"D Peng","year":"2011","unstructured":"Peng D, Hiipakka RA, Xie JT, et al. A novel potent synthetic steroidal liver X receptor agonist lowers plasma cholesterol and triglycerides and reduces atherosclerosis in LDLR(-\/-) mice. Br J Pharmacol. 2011;162(8):1792\u2013804.","journal-title":"Br J Pharmacol"},{"key":"1216_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.973612","volume":"13","author":"N Li","year":"2022","unstructured":"Li N, Li Y, Han X, et al. Lxr agonist inhibits inflammation through regulating MyD88 mrna alternative splicing. Front Pharmacol. 2022;13:973612.","journal-title":"Front Pharmacol"},{"issue":"7","key":"1216_CR30","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.1002\/jcp.30204","volume":"236","author":"L Zhao","year":"2021","unstructured":"Zhao L, Lei W, Deng C, et al. The roles of liver X receptor alpha in inflammation and inflammation-associated diseases. J Cell Physiol. 2021;236(7):4807\u201328.","journal-title":"J Cell Physiol"},{"issue":"10","key":"1216_CR31","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1093\/ibd\/izab034","volume":"27","author":"J Miranda-Bautista","year":"2021","unstructured":"Miranda-Bautista J, Rodriguez-Feo JA, Puerto M, et al. Liver x receptor exerts anti-inflammatory effects in colonic epithelial cells via ABCA1 and its expression is decreased in human and experimental inflammatory bowel disease. Inflamm Bowel Dis. 2021;27(10):1661\u201373.","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"1216_CR32","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.tips.2024.08.003","volume":"45","author":"P Wangchuk","year":"2024","unstructured":"Wangchuk P, Yeshi K, Loukas A. Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments. Trends Pharmacol Sci. 2024;45(10):892\u2013903.","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"1216_CR33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3748\/wjg.v17.i2.197","volume":"17","author":"V Andersen","year":"2011","unstructured":"Andersen V, Christensen J, Ernst A, et al. Polymorphisms in NF-kappaB, PXR, LXR, PPARgamma and risk of inflammatory bowel disease. World J Gastroenterol. 2011;17(2):197\u2013206.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"1216_CR34","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1080\/14712598.2019.1666101","volume":"20","author":"C Le Berre","year":"2020","unstructured":"Le Berre C, Roda G, Nedeljkovic Protic M, et al. Modern use of 5-aminosalicylic acid compounds for ulcerative colitis. Expert Opin Biol Ther. 2020;20(4):363\u201378.","journal-title":"Expert Opin Biol Ther"},{"issue":"7","key":"1216_CR35","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1096\/fj.201600244R","volume":"30","author":"S Yu","year":"2016","unstructured":"Yu S, Li S, Henke A, et al. Dissociated sterol-based liver X receptor agonists as therapeutics for chronic inflammatory diseases. FASEB J. 2016;30(7):2570\u20139.","journal-title":"FASEB J"},{"issue":"1","key":"1216_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-024-00207-w","volume":"5","author":"Y Liang","year":"2024","unstructured":"Liang Y, Li Y, Lee C, et al. Ulcerative colitis: molecular insights and intervention therapy. Mol Biomed. 2024;5(1):42.","journal-title":"Mol Biomed"},{"key":"1216_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctmp.2024.200152","author":"X Jin","year":"2024","unstructured":"Jin X, Wang X, Li X, et al. Appraising the quality of clinical practice guidelines in Chinese patent medicine. Clin Tradit Med Pharmacol. 2024. https:\/\/doi.org\/10.1016\/j.ctmp.2024.200152.","journal-title":"Clin Tradit Med Pharmacol"},{"key":"1216_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccmp.2024.100129","author":"MN Mugale","year":"2024","unstructured":"Mugale MN, Dev K, More BS, et al. A comprehensive review on preclinical safety and toxicity of medicinal plants. Clin Complement Med Pharmacol. 2024. https:\/\/doi.org\/10.1016\/j.ccmp.2024.100129.","journal-title":"Clin Complement Med Pharmacol"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01216-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-025-01216-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01216-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:03:34Z","timestamp":1759277014000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-025-01216-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1216"],"URL":"https:\/\/doi.org\/10.1186\/s13020-025-01216-9","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments in this study were authorized by animal ethics Committee of Hangzhou Medical College (Approval NO. ZJCLA-IACUC-20020147). Male C57BL\/6\u00a0J mice were purchased from the Experimental Animal Center of Hangzhou Medical College (Hangzhou, China) and cared for humanely according to Hangzhou Medical College's institutional animal ethics guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to the publication of this work in Chinese Medicine.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"152"}}